Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1988227rdf:typepubmed:Citationlld:pubmed
pubmed-article:1988227lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:1988227lifeskim:mentionsumls-concept:C0010453lld:lifeskim
pubmed-article:1988227lifeskim:mentionsumls-concept:C0021760lld:lifeskim
pubmed-article:1988227lifeskim:mentionsumls-concept:C0026473lld:lifeskim
pubmed-article:1988227lifeskim:mentionsumls-concept:C0227651lld:lifeskim
pubmed-article:1988227lifeskim:mentionsumls-concept:C0021755lld:lifeskim
pubmed-article:1988227lifeskim:mentionsumls-concept:C0596290lld:lifeskim
pubmed-article:1988227lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:1988227lifeskim:mentionsumls-concept:C0033268lld:lifeskim
pubmed-article:1988227pubmed:issue1lld:pubmed
pubmed-article:1988227pubmed:dateCreated1991-2-22lld:pubmed
pubmed-article:1988227pubmed:abstractTextConditioned media from human peripheral blood leucocytes treated with lipopolysaccharide (LPS) induced a marked increase in the 3H-thymidine incorporation of cultured mesangial cells at low serum concentration (four to six times higher than control). Two sizes (100-70 and 8-12 kD) of monocyte-derived mesangial cell proliferating factors (MDF) were separated by column chromatography. Their peaks were distinct from those of thymocyte proliferating activity. The addition of anti-human interleukin-1 (IL-1) or anti-recombinant human interleukin-6 (IL-6) antibody to the fractionated MDF failed to have any effect on the mitogenic activity toward mesangial cells. The addition of anti-human platelet-derived growth factor (PDGF) antibody to the low molecular weight fraction decreased mesangial cell mitogenic activity (40-60% of control), but addition to the higher fraction did not (80-100% of control). From these data it seems that a large portion of the monocyte-derived mesangial cell growth factor was not comprised of IL-1 or IL-6 but of PDGF-like molecules; and that there is an unknown mesangial cell proliferating factor (or factors) besides IL-1, IL-6 and PDGF.lld:pubmed
pubmed-article:1988227pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1988227pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1988227pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1988227pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1988227pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1988227pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1988227pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1988227pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1988227pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1988227pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1988227pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1988227pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1988227pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1988227pubmed:languageenglld:pubmed
pubmed-article:1988227pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1988227pubmed:citationSubsetIMlld:pubmed
pubmed-article:1988227pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1988227pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1988227pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1988227pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1988227pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1988227pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1988227pubmed:statusMEDLINElld:pubmed
pubmed-article:1988227pubmed:monthJanlld:pubmed
pubmed-article:1988227pubmed:issn0009-9104lld:pubmed
pubmed-article:1988227pubmed:authorpubmed-author:ShimizuFFlld:pubmed
pubmed-article:1988227pubmed:authorpubmed-author:MoriokaTTlld:pubmed
pubmed-article:1988227pubmed:authorpubmed-author:OiteTTlld:pubmed
pubmed-article:1988227pubmed:authorpubmed-author:NaritaIIlld:pubmed
pubmed-article:1988227pubmed:issnTypePrintlld:pubmed
pubmed-article:1988227pubmed:volume83lld:pubmed
pubmed-article:1988227pubmed:ownerNLMlld:pubmed
pubmed-article:1988227pubmed:authorsCompleteYlld:pubmed
pubmed-article:1988227pubmed:pagination182-6lld:pubmed
pubmed-article:1988227pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:1988227pubmed:meshHeadingpubmed-meshheading:1988227-...lld:pubmed
pubmed-article:1988227pubmed:meshHeadingpubmed-meshheading:1988227-...lld:pubmed
pubmed-article:1988227pubmed:meshHeadingpubmed-meshheading:1988227-...lld:pubmed
pubmed-article:1988227pubmed:meshHeadingpubmed-meshheading:1988227-...lld:pubmed
pubmed-article:1988227pubmed:meshHeadingpubmed-meshheading:1988227-...lld:pubmed
pubmed-article:1988227pubmed:meshHeadingpubmed-meshheading:1988227-...lld:pubmed
pubmed-article:1988227pubmed:meshHeadingpubmed-meshheading:1988227-...lld:pubmed
pubmed-article:1988227pubmed:meshHeadingpubmed-meshheading:1988227-...lld:pubmed
pubmed-article:1988227pubmed:meshHeadingpubmed-meshheading:1988227-...lld:pubmed
pubmed-article:1988227pubmed:meshHeadingpubmed-meshheading:1988227-...lld:pubmed
pubmed-article:1988227pubmed:meshHeadingpubmed-meshheading:1988227-...lld:pubmed
pubmed-article:1988227pubmed:meshHeadingpubmed-meshheading:1988227-...lld:pubmed
pubmed-article:1988227pubmed:meshHeadingpubmed-meshheading:1988227-...lld:pubmed
pubmed-article:1988227pubmed:meshHeadingpubmed-meshheading:1988227-...lld:pubmed
pubmed-article:1988227pubmed:meshHeadingpubmed-meshheading:1988227-...lld:pubmed
pubmed-article:1988227pubmed:meshHeadingpubmed-meshheading:1988227-...lld:pubmed
pubmed-article:1988227pubmed:meshHeadingpubmed-meshheading:1988227-...lld:pubmed
pubmed-article:1988227pubmed:year1991lld:pubmed
pubmed-article:1988227pubmed:articleTitleProduction by cultured human monocytes of mesangial cell proliferation factor(s) differing from interleukin-1 and interleukin-6.lld:pubmed
pubmed-article:1988227pubmed:affiliationDepartment of Immunology, Niigata University School of Medicine, Japan.lld:pubmed
pubmed-article:1988227pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1988227pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1988227lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1988227lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1988227lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1988227lld:pubmed